These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 19881403

  • 21. PK-PD curve-fitting problems with the Hill equation? Try one of the 1-exp functions derived from Hodgkin, Douglas or Gompertz.
    Keller F, Giehl M, Czock D, Zellner D.
    Int J Clin Pharmacol Ther; 2002 Jan; 40(1):23-9. PubMed ID: 11837379
    [Abstract] [Full Text] [Related]

  • 22. An algebraic model to determine substrate kinetic parameters by global nonlinear fit of progress curves.
    Reytor González ML, Cornell-Kennon S, Schaefer E, Kuzmič P.
    Anal Biochem; 2017 Feb 01; 518():16-24. PubMed ID: 27823930
    [Abstract] [Full Text] [Related]

  • 23. Improved rearrangement of the integrated Michaelis-Menten equation for calculating in vivo kinetics of transport and metabolism.
    Russell RW, Drane JW.
    J Dairy Sci; 1992 Dec 01; 75(12):3455-64. PubMed ID: 1474212
    [Abstract] [Full Text] [Related]

  • 24. About and beyond the Henri-Michaelis-Menten rate equation for single-substrate enzyme kinetics.
    Bajzer Z, Strehler EE.
    Biochem Biophys Res Commun; 2012 Jan 20; 417(3):982-5. PubMed ID: 22206668
    [Abstract] [Full Text] [Related]

  • 25. Application of modified Michaelis - Menten equations for determination of enzyme inducing and inhibiting drugs.
    Saganuwan SA.
    BMC Pharmacol Toxicol; 2021 Oct 11; 22(1):57. PubMed ID: 34635182
    [Abstract] [Full Text] [Related]

  • 26. Integrated equation to evaluate accumulation profiles of drugs eliminated by Michaelis-Menten kinetics.
    Lam G, Chiou WL.
    J Pharmacokinet Biopharm; 1979 Apr 11; 7(2):227-32. PubMed ID: 20218016
    [Abstract] [Full Text] [Related]

  • 27. Use of a programmable calculator to determine steady-state levels of drugs eliminated by parallel first-order and Michaelis-Menten kinetics.
    Crow JW, Levy G.
    Am J Hosp Pharm; 1978 Sep 11; 35(9):1075-7. PubMed ID: 696752
    [Abstract] [Full Text] [Related]

  • 28. Ethanol pharmacokinetics in healthy man: Michaelis-Menten parameters and the circadian rhythm.
    Minors DS, Waterhouse JM.
    Chronobiologia; 1985 Sep 11; 12(2):137-44. PubMed ID: 4028905
    [Abstract] [Full Text] [Related]

  • 29. [Therapeutic drug monitoring of itraconazole--a report of experiences].
    Lampe D, Kreutzberg S, Prümke HJ.
    Mycoses; 1994 Sep 11; 37 Suppl 2():34-9. PubMed ID: 7609741
    [Abstract] [Full Text] [Related]

  • 30. Parametric analysis of the errors associated with the Michaelis-Menten equation.
    Brown RF, Holtzapple MT.
    Biotechnol Bioeng; 1990 Dec 20; 36(11):1141-50. PubMed ID: 18595055
    [Abstract] [Full Text] [Related]

  • 31. Kinlsq: a program for fitting kinetics data with numerically integrated rate equations and its application to the analysis of slow, tight-binding inhibition data.
    Gutheil WG, Kettner CA, Bachovchin WW.
    Anal Biochem; 1994 Nov 15; 223(1):13-20. PubMed ID: 7695087
    [Abstract] [Full Text] [Related]

  • 32. Sigmoidal substrate saturation curves in Michaelis-Menten mechanism as an artefact.
    Fischer E, Keleti T.
    Acta Biochim Biophys Acad Sci Hung; 1975 Nov 15; 10(3):221-7. PubMed ID: 1211106
    [Abstract] [Full Text] [Related]

  • 33. Michaelis-Menten equation and detailed balance in enzymatic networks.
    Cao J.
    J Phys Chem B; 2011 May 12; 115(18):5493-8. PubMed ID: 21466190
    [Abstract] [Full Text] [Related]

  • 34. Influence of bioavailability on the calculated Michaelis-Menten parameters of phenytoin in children.
    Koren G, Brand N, MacLeod SM.
    Ther Drug Monit; 1984 May 12; 6(1):11-4. PubMed ID: 6710554
    [Abstract] [Full Text] [Related]

  • 35. Another integrated form of the Michaelis-Menten equation, its analogy to electrical circuit model and implications for active transporters.
    Wu G.
    Med Hypotheses; 2000 May 12; 54(5):748-9. PubMed ID: 10859681
    [Abstract] [Full Text] [Related]

  • 36. Simulation for population analysis of Michaelis-Menten elimination kinetics.
    Hashimoto Y, Koue T, Otsuki Y, Yasuhara M, Hori R, Inui K.
    J Pharmacokinet Biopharm; 1995 Apr 12; 23(2):205-16. PubMed ID: 8719237
    [Abstract] [Full Text] [Related]

  • 37. Explicit reformulations of the Lambert W-omega function for calculations of the solutions to one-compartment pharmacokinetic models with Michaelis-Menten elimination kinetics.
    Goličnik M.
    Eur J Drug Metab Pharmacokinet; 2011 Sep 12; 36(3):121-7. PubMed ID: 21533844
    [Abstract] [Full Text] [Related]

  • 38. A new graphical method for determining parameters in Michaelis-Menten-type kinetics for enzymatic lactose hydrolysis.
    Yang ST, Okos MR.
    Biotechnol Bioeng; 1989 Sep 12; 34(6):763-73. PubMed ID: 18588163
    [Abstract] [Full Text] [Related]

  • 39. Phenytoin Michaelis-Menten pharmacokinetics in Saudi patients.
    el-Sayed YM, Islam SI.
    Int J Clin Pharmacol Ther Toxicol; 1989 Apr 12; 27(4):173-8. PubMed ID: 2714918
    [Abstract] [Full Text] [Related]

  • 40. Shortcut formulae for pharmacokinetic dosage adjustments.
    Belloto RJ.
    Clin Pharmacokinet; 2009 Apr 12; 48(9):555-60. PubMed ID: 19725590
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.